These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6999981)

  • 1. Randomized trial of high- and low-dose ampicillin therapy for treatment of severe dysentery due to Shigella dysenteriae type 1.
    Gilman RH; Koster F; Islam S; McLaughlin J; Rahaman MM
    Antimicrob Agents Chemother; 1980 Mar; 17(3):402-5. PubMed ID: 6999981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing pattern of resistant Shiga bacillus (Shigella dysenteriae type 1) and Shigella flexneri in Bangladesh.
    Shahid NS; Rahaman MM; Haider K; Banu H; Rahman N
    J Infect Dis; 1985 Dec; 152(6):1114-9. PubMed ID: 3905980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of furazolidone therapy in shigellosis.
    Haltalin KC; Nelson JD
    Am J Dis Child; 1972 Jan; 123(1):40-4. PubMed ID: 4551612
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery.
    Yunus M; Mizanur Rahman AS; Farooque AS; Glass RI
    J Trop Med Hyg; 1982 Oct; 85(5):195-9. PubMed ID: 6757458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shigellosis in children: a clinico-epidemiological comparison between Shigella dysenteriae type I and Shigella flexneri.
    Faruque AS; Teka T; Fuchs GJ
    Ann Trop Paediatr; 1998 Sep; 18(3):197-201. PubMed ID: 9924557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxicillin less effective than ampicillin against Shigella in vitro and in vivo: relationship of efficacy to activity in serum.
    Nelson JA; Haltalin KC
    J Infect Dis; 1974 Jun; 129(0):suppl:S222-7. PubMed ID: 4601191
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial.
    Kabir I; Butler T; Khanam A
    Antimicrob Agents Chemother; 1986 Apr; 29(4):645-8. PubMed ID: 3518625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intramuscular and oral ampicillin therapy for shigellosis.
    Haltalin KC; Nelson JD; Kusmiesz HT; Hinton LV
    J Pediatr; 1968 Oct; 73(4):617-22. PubMed ID: 4878056
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children.
    Varsano I; Eidlitz-Marcus T; Nussinovitch M; Elian I
    J Pediatr; 1991 Apr; 118(4 Pt 1):627-32. PubMed ID: 2007941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithms in the diagnosis and management of exotic diseases. XXVII. Shigellosis.
    Butler T; Mahmoud AA; Warren KS
    J Infect Dis; 1977 Sep; 136(3):465-8. PubMed ID: 333040
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.
    Haltalin KC; Nelson JD; Ring R; Sladoje M; Hinton LV
    J Pediatr; 1967 Jun; 70(6):970-81. PubMed ID: 5338090
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute diarrhea in outpatients. Double-blind study comparing ampicillin and placebo.
    Haltalin KC; Kusmiesz HT; Hinton LV; Nelson JD
    Am J Dis Child; 1972 Oct; 124(4):554-61. PubMed ID: 4562790
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis.
    Kabir I; Rahaman MM; Ahmed SM; Akhter SQ; Butler T
    Antimicrob Agents Chemother; 1984 May; 25(5):643-5. PubMed ID: 6329092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.
    Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q
    BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose ampicillin therapy for severe shigellosis in Bangladesh.
    Gilman RH; Spira W; Rabbani H; Ahmed W; Islam A; Rahaman MM
    J Infect Dis; 1981 Feb; 143(2):164-9. PubMed ID: 7012247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled clinical trial of trimethoprim-sulphamethoxazole in shigella dysentery.
    Mabadeje AF
    J Trop Med Hyg; 1974 Mar; 77(3):50-4. PubMed ID: 4598139
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania.
    Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM
    Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk areas and neighborhood-level risk factors for Shigella dysenteriae 1 and Shigella flexneri.
    Emch M; Ali M; Yunus M
    Health Place; 2008 Mar; 14(1):96-105. PubMed ID: 17602851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.